Author

Heather Nutsch

Institution: University of Nebraska Medical Center

Observed institutions: Nebraska Medical Center, University of Nebraska Medical Center

OpenAlex ID: A5052070772

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

2023 · Adam S. Zayac, Daniel J. Landsburg, et al. · Blood Advances · 34

Phase I/ II study of dasatinib and exploratory genomic analysis in relapsed or refractory non‐Hodgkin lymphoma

2018 · Jayadev M. Umakanthan, Javeed Iqbal, et al. · British Journal of Haematology · 27

High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Characteristics, Treatment, and Outcomes from 17 Academic US Centers

2021 · Adam Zayac, Daniel J Landsburg, et al. · Blood · 4

High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series

2022 · Narendranath Epperla, Adam Zayac, et al. · Blood · 3

Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes

2020 · Amulya Yellala, Elizabeth R. Lyden, et al. · Blood · 2

Works count: 5

Citation count: 70

H-index: 3

I10-index: 2